Mubadala Capital

Activity from announced rounds

Activity in this selectionOct 6, 2026 · AI · Jan 1, 2026

Mubadala Capital is the investment manager whose official portfolio includes Ollin, Alloy, Juvena and Crusoe.

Recorded funding activity

Ollin develops retinal-disease antibodies. Alloy supplies discovery platforms and services, while Crusoe develops computing infrastructure. The manager remains separate from Mubadala Investment Company; the Precision Neuroscience relation stays in draft.

Sources
Rounds participated in
4
Confirmed lead rounds
1
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$20B
4 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series B1
Undisclosed1

By primary sector

Biotech2
AI1
Mobility1

By country

United States4

Rounds

4 in this selection
Crusoe

AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises.

$3.9BSeries F (initial close; anticipated total)
Lead
Alloy Therapeutics

Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.

$40MSeries E
Role not disclosed
Waymo

Waymo develops autonomous driving technology and operates a fully driverless ride-hailing service.

$16BInvestment round
Participant